# Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

> **NCT06986018** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Idiopathic Inflammatory Myopathies
- ANCA-Associated Vasculitis

## Interventions

- **DRUG:** RD06-04 Cell Injection Infusion

## Key facts

- **NCT ID:** NCT06986018
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-14
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06986018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06986018, "Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06986018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*